Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125412851 | 12541285 | 1 | I | 20160629 | 20160708 | 20160708 | EXP | US-MEDA-2016060114 | MEDA | ROCCI E,PARK, MD, MS K,HUTCHENS, MD K,WINTERFIELD, MD, MPH L. FIRST REPORT OF MESALAMINE (5-AMINOSALICYLIC ACID) AS THE CAUSATIVE AGENT IN A CASE OF ACUTE GENERALIZED EXANTHAMOUS PUSTULOSIS. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 2016; 74(1): AB171 | 73.00 | YR | E | M | Y | 0.00000 | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125412851 | 12541285 | 1 | PS | MESALAMINE. | MESALAMINE | 1 | Y | 19618 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125412851 | 12541285 | 1 | Colitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125412851 | 12541285 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125412851 | 12541285 | Acute generalised exanthematous pustulosis | |
| 125412851 | 12541285 | Renal failure | |
| 125412851 | 12541285 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |